59 years old, PhD in Biology, Research Scientist at the CSIC.

of CSIC, he leads the Molecular Pharmacology group in the Department of Molecular Biomedicine of the Centre for Biological Research (CIP-CSIC).

36 years of experience in research, 22 years in academic institutions. 14 years in R&D in the pharmaceutical industry, 12 years as R&D Director in the international area of Drug Discovery at Merck, Sharp & Dohme, SmithKline Beecham and PharmaMar. Member of the International R&D Scientific Committee of these pharmaceutical companies.

Author of 46 publications in international journals and responsible for 40 international patents for new compounds and processes. Invited lecturer at national and international public and private research institutions.

Evaluator for the European Commission, Ministry of Education and Science and the Ministry of Industry, member of the Steering Committee of European Consortia as representative of MINECO (ERA-NETs and JPIs). Consultant to pharmaceutical and biotechnology companies (e.g., Genentech, GlaxoSmithKline, MGMis, Mejor@n, eYOWN, DOMCA).

Founder of two biomedical biotechnology companies, BioSafety and EYOWN.